吸入依洛前列环素对先天性心脏病继发肺动脉高压患者血液动力学的影响

    Hemodynamic effects of aerosolized iloprost on pulmonary hypertension of patients with congenital heart disease

    • 摘要: 目的:探讨吸入依洛前列环素对先天性心脏病(CHD)继发肺动脉高压(PAH)患者的血液动力学影响。方法:对20例CHD继发PAH患者吸入依洛前列环素,分别测量吸入药物前后各血液动力学参数,比较用药前后的差异。结果:吸入依洛前列环素后PAH患者的肺动脉收缩压(PAP)、肺动脉舒张压、肺动脉平均压、肺血管阻力(PVR)下降,外周动脉血血氧饱和度、周围动脉氧分压、体循环血流量、肺循环血流量、心脏指数(CI)增加;混合静脉血氧含量、体循环收缩压、混合静脉血血氧饱和度、体循环舒张压、体循环平均压、肺小动脉嵌顿压、心率无明显变化。结论:吸入依洛前列环素可安全有效地降低PAH患者的PAP、PVR,增加CI。

       

      Abstract: Objective: To investigate the hemodynamic effects of aerosolized iloprost on pulmonary hypertension(PAH) of patients with congenital heart disease(CHD).Methods: Before and after inhaled iloprost hemodynamic parameters was measure in 20 PAH patients with CHD.Results: Iloprost inhalation can decreased systolic pulmonary artery pressure,diastolic pulmonary artery pressure(PAP),mean pulmonary artery pressure,and pulmonary vascular resistance(PVR).Iloprost inhalation increased systemic arterial oxygen saturation,systemic arterial partial pressure of oxygen,systemic blood flow,pulmonary blood flow and cardiac index(CI).And there was no significant influence on mixed venous oxygen content,mixed venous oxygen saturation,systolic arterial pressure,diastolic arterial pressure,mean systemic arterial pressure,pulmonary artery wedge pressure and heart rate.Conclusions: Aerosolized iloprost can safely and effectively decrease PAP,PVR and increase CI.

       

    /

    返回文章
    返回